News /

Filtered:

RUO Chemistry Reagents (Remove filters)

BioPorto receives Frost & Sullivan Award

Frost & Sullivan awards AKI Product Leadership Award to BioPorto

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

Acute Kidney Biomarkers in focus in renown clinical issue

American Association for Clinical Chemistry (AACC) push for AKI biomarkers including NGAL in new cover story

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

The NGAL Test™ for users of Siemens VISTA and BC UniCel® DxC 800

We are happy to announce that The NGAL Test™ application notes are now available for the Siemens Dimension Vista® Integrated Chemistry System's nephelometric chanel and the turbidemetric analyzer from Beckman Coulter UniCel® DxC 800 Synchron® Clinical System. Both application notes are designed for urine samples only.

Read more
Category
Diagnostics, Research
Date

The NGAL Test™ available for users of Siemens instruments

We are happy to announce that The NGAL Test™ is now available for the Siemens ADVIA 1800 analyzer.
Together with Roche and Abbott, Siemens is a leading supplier of instruments for laboratory diagnostics worldwide and has a large number of ADVIA systems placed in first-class laboratories. This means that considerably more hospitals and testing sites can now start working with BioPorto's automated NGAL test.

Read more
Date

Huber W (2012) J CLI 36:10-12

Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.

To download as pdf please click here 

Read more
Source
http://www.cli-online.com/featured-articles/early-detection-of-acute-kidney-injury-in-sepsis-how-about-ngal/index.html
Date

Ostermann M (2011) J CLI 35:10-12

Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising biomarker for acute kidney injury (AKI). The ultimate goal is for NGAL to enable clinicians to intervene as early as possible and to change the prognosis of AKI.

To download as pdf please click here

Read more
Source
http://www.cli-online.com/index.php?id=3198
Date